ACA

Avoro Capital Advisors Portfolio holdings

AUM $10.2B
1-Year Est. Return 119.92%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+119.92%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$10.2B
AUM Growth
+$2.44B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
41
New
Increased
Reduced
Closed

Top Buys

1
+$272M
2
+$256M
3
+$241M
4
RVMD icon
Revolution Medicines
RVMD
+$142M
5
TERN icon
Terns Pharmaceuticals
TERN
+$101M

Top Sells

1
+$334M
2
+$188M
3
+$141M
4
TRML
Tourmaline Bio
TRML
+$122M
5
FOLD icon
Amicus Therapeutics
FOLD
+$118M

Sector Composition

1 Healthcare 97.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALKS icon
26
Alkermes
ALKS
$5.63B
$39.2M 0.39%
1,400,000
-840,000
APGE icon
27
Apogee Therapeutics
APGE
$6.6B
$37.7M 0.37%
+500,000
SEPN
28
Septerna Inc
SEPN
$1.08B
$37.3M 0.37%
1,337,500
LXEO icon
29
Lexeo Therapeutics
LXEO
$494M
$32.8M 0.32%
+3,300,000
MNKD icon
30
MannKind Corp
MNKD
$846M
$25.2M 0.25%
4,444,444
-24,433
GHRS icon
31
GH Research
GHRS
$1.04B
$22.9M 0.22%
+1,800,000
INCY icon
32
Incyte
INCY
$19.4B
$13.3M 0.13%
+135,000
WHWK
33
Whitehawk Therapeutics
WHWK
$189M
$6.9M 0.07%
2,849,402
TRML
34
DELISTED
Tourmaline Bio
TRML
– –
-2,555,555
TNGX icon
35
Tango Therapeutics
TNGX
$3.43B
– –
-545,000
MRUS
36
DELISTED
Merus
MRUS
– –
-3,542,500
MLTX icon
37
MoonLake Immunotherapeutics
MLTX
$1.35B
– –
-2,000,000
FOLD icon
38
Amicus Therapeutics
FOLD
$4.54B
– –
-15,025,000
ETNB
39
DELISTED
89bio
ETNB
– –
-6,387,790
BCRX icon
40
BioCryst Pharmaceuticals
BCRX
$2.43B
– –
-1,250,000
AKRO
41
DELISTED
Akero Therapeutics
AKRO
– –
-3,955,555
1
2